Startups
Edit

Artificial Intelligence for Breast Cancer Screening

http://www.mammoscreen.com/
Last activity: 25.10.2022
Active
MammoScreen™ is an AI-based software that provides AI-guided decision-making support for breast cancer screening. It works alongside your viewer to provide an expert, confirming look at a mammogram, without disrupting your workflow. It is designed to enhance workflow, with side-by-side monitor interface and dedicated monitor provides at-a-glance decision-making support. MammoScreen® 2D&3D provides AI-guided decision-making support for breast cancer screening, enabling you to decisively confirm what you suspect, detect what you potentially missed and concentrate on questionable studies that need more attention.
Website visits
6.8K /mo.
Mentions
4

Mentions in press and media 4

DateTitleDescription
Sign up to seeSign up to seeSign up to see
May 12, 2022Therapixel raises €15 million to boost AI-driven mammography readingThe French company specialising in design and commercialisation of AI-powered medical imaging software, Therapixel has raised €15 million in Series B funding. The new capital will boost its commercial presence in the U.S. The funding will a...
Jan 12, 2021Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™ USA - English France - Français España - español Deutschland - Deutsch
Therapixel raises €15 million to boost AI-driven mammography readingThe French company specialising in design and commercialisation of AI-powered medical imaging software, Therapixel has raised €15 million in Series B funding. The new capital will boost its commercial presence in the U.S. The funding will a...

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Artificial Intelligence for Breast Cancer Screening

What has the press written about Artificial Intelligence for Breast Cancer Screening?

Parsers VC has collected 4 articles mentioning Artificial Intelligence for Breast Cancer Screening, among them “Therapixel raises €15 million to boost AI-driven mammography reading” (May 12, 2022) and “Therapixel receives the CE mark for its Artificial Intelligence-based software (AI) MammoScreen™ USA - English France - Français España - español Deutschland...” (Jan 12, 2021).

Is Artificial Intelligence for Breast Cancer Screening still active?

Yes, Artificial Intelligence for Breast Cancer Screening is active; its latest activity on Parsers VC dates from Oct 25, 2022.